Acrivon Therapeutics, Inc. - COMMON STOCK (ACRV)

Historical Holders from Q4 2022 to Q1 2025

Symbol
ACRV on Nasdaq
CUSIP
004890109
Type / Class
Equity / COMMON STOCK
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
23.2M
Holdings value
$140M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
59
Number of buys
24
Number of sells
-18
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Acrivon Therapeutics, Inc. - COMMON STOCK (ACRV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 40K $81.3K +$3.88K $2.03 3
2024 Q4 23.2M $140M -$971K $6.02 59
2024 Q3 23M $161M -$2.68M $7.00 51
2024 Q2 23.5M $136M +$47.4M $5.80 51
2024 Q1 15.2M $109M +$3.45M $7.15 45
2023 Q4 14.9M $73.1M +$884K $4.92 39
2023 Q3 15.1M $144M -$326K $9.56 43
2023 Q2 15.1M $196M -$1.15M $12.96 40
2023 Q1 15.2M $191M +$6.82M $12.69 39
2022 Q4 14.5M $166M +$165M $11.52 17